Placebo Optimization of the Presurgical Long-term Video-EEG Monitoring

Launched by UNIVERSITY HOSPITAL, BONN · Apr 22, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring how a placebo, which is a treatment that looks like a real medication but has no active ingredients, might affect people with symptomatic epilepsy before they undergo surgery. The study aims to find out if using a placebo can change the timing of a person's first seizure or improve their feelings of well-being during the long-term video-EEG monitoring process. Researchers believe that while the placebo may help people feel better, it will not actually change the occurrence of seizures.

If you or a loved one is between the ages of 65 and 74 and are eligible for presurgical epilepsy diagnostics, you may qualify to participate in this trial. Participants will be monitored closely, and they can expect to receive either a placebo that aims to improve comfort or a placebo focused on delaying seizures. It’s important to note that anyone who cannot provide consent or has a legal guardian cannot participate. This trial is currently looking for volunteers, so if you meet the criteria and are interested, it could be a great opportunity to contribute to important research in epilepsy care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • eligibility for presurgical epilepsy diagnostics
• Exclusion Criteria:
• • inclusion criterion implies all exclusion criteria for this procedure
• • legal guardian
• • lack of consent or lack of capability to provide informed consent